Worksport FY 2025 slides: revenue doubles, margins surge to 28%

Worksport reported FY2025 net sales of $16.1M, up 89.8% y/y from $8.5M, with gross margin expanding to 28% (Q4 30.1%) driven by a shift away from private-label sales and manufacturing efficiencies. Management guided FY2026 revenue of $35-42M (midpoint $38.5M, ~140% growth) and ~35% gross margin, while ending 2025 with $5.95M cash + $3.4M revolver ($9.3M total) and a $17.2M cash burn in 2025. The company commercialized SOLIS and COR (initial near-term revenue ~$2.5M), scaled production (125+ units/shift) and expanded dealers from 92 to >550, but retains a going-concern disclosure making execution and achieving operational cash-flow positivity in H2 2026 the primary risks.

Analysis

The operational progress here creates asymmetric optionality rather than a clean earnings multiple story — the real value lies in two binary edges: (1) conversion of dealer and OEM distribution into recurring aftermarket replacement economics and (2) monetization of energy/storage IP into higher-margin, adjacently addressable markets. If both edges materialize, revenue on a fixed-capacity base and aftermarket repurchase rates can create rapid incremental gross margin expansion; if one fails, fixed-cost leverage flips to cash-burn risk.

Second-order beneficiaries include Tier-1 module and battery-cell suppliers with flexible MOQ profiles and logistics providers that can compress lead times into the Midwest/South corridor; conversely, incumbent portable-power standalone vendors and low-margin private-label manufacturers face share pressure and margin compression. Execution risks concentrate in supply chain sequencing (cells, inverter electronics), warranty costs for nascent products, and the timing mismatch between commercial rollout and longer OEM procurement cycles.

Near-term catalysts that will re-rate the equity are concrete multi-dealer sell-through data, a signed OEM/B2B offtake or supply agreement, and demonstrable unit economics at scale (net contribution margin per unit). The main bear scenarios are renewed cash strain forcing punitive dilution, SKU-level returns or reliability issues that spike warranty reserves, or longer-than-expected OEM decision timelines — each can manifest within quarters and should shape position sizing.

Key Decisions for Investors

• Small-sized core position: Initiate a tactical long in WKSP sized ~1-2% of portfolio using cash equity; horizon 6-12 months. Risk management: hard stop at -50% from entry or scale out if one of the key catalysts (dealer sell-through or OEM announcement) is achieved. Reward: asymmetric upside if commercial cadence and B2B deals de-risk execution.
• Defined-risk options trade: Buy a 12–18 month call spread in WKSP to limit premium outlay (buy nearer-term LEAP call, sell a higher-strike LEAP). Position size: max premium = 0.5–1.0% portfolio. Rationale: preserves upside exposure to execution/certification catalysts while capping downside to premium paid.
• Event-driven wait/scale approach: Do not add size until one of two binary proofs occurs (public OEM/B2B contract or two consecutive quarters of positive unit-level contribution and low return rates). If one proof appears, scale to 3–4% of portfolio; if neither occurs in 6–9 months, exit remaining exposure to avoid dilution tail risk.
• Relative allocation alternative: If unwilling to take pure execution risk, allocate to higher-quality, revenue-generating alternatives (e.g., SMCI or APP) with clearer cash-flow paths and use the saved capital to buy WKSP options for asymmetric upside. This preserves upside exposure while prioritizing cash-flow stability.